You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
SUN PHARMACEUTICAL INDUSTRIES INCFDAMed source confidence · 83%Jul 8, 2026, 4:47 AM UTC · 9h ago

SUN PHARMACEUTICAL INDUSTRIES INC — FDA Class II (D-0628-2026)

Case File

SUN PHARMACEUTICAL INDUSTRIES INC is recalling 3,456 bottles of a human medication due to a labeling mix-up. The recall is due to incorrect labeling of the 10mg dosage. This is a Class II recall, indicating a temporary health issue.

Sign in to follow SUN PHARMACEUTICAL INDUSTRIES INC and get alerts like this
Key Points
  • SUN PHARMACEUTICAL INDUSTRIES INC is recalling 3,456 bottles of a medication.
  • The recall is due to a labeling mix-up for the 10mg dosage.
  • This is classified as a Class II recall.
  • Consumers should check their medicine cabinets for affected products.
  • Recall actions like this are taken to prevent potential health risks.
Why This Matters

Consumers who have these bottles should stop using them and contact the firm for further instructions. The labeling issue could lead to incorrect medication usage.

View original filing →
Sign in to follow SUN PHARMACEUTICAL INDUSTRIES INC and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.